NSECertificate under SEBI (Depositories and Participants) Regulations, 20187 Jul 2026 · 7 Jul 2026, 06:29 pm

Certificate under SEBI (Depositories and Participants) Regulations, 2018

Aarti Drugs Limited · AARTIDRUGS

✦ AI Summary

Aarti Drugs Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018, confirming the dematerialisation of securities and listing on stock exchanges.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Aarti Drugs Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018

Attachments (1)

📄

AARTIDRUGS_07072026182922_ADL.pdf

pdf

Download →
View document text
Ref: ADL/SE/2026-27/22 July 7, 2026 To, To, Listing/ Compliance Department Listing/ Compliance Department BSE LTD. National Stock Exchange of India Phiroze Jeejeebhoy Towers Limited Dalal Street, “Exchange Plaza”, Plot No C/1, Mumbai 400 001 G Block, Bandra Kurla Complex, Bandra (E), Mumbai 400 051 BSE CODE: 524348 NSE SYMBOL: AARTIDRUGS Sir/ Madam, Ref: Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 Please find enclose herewith a Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended June 30, 2026 received from MUFG Intime India Private Limited (Formerly Link Intime India Private Limited), Registrar and Transfer Agent of our Company. You are requested to take the same on records. Thanking you, Yours Faithfully, FOR AARTI DRUGS LIMITED RUSHIKESH DEOLE COMPANY SECRETARY & COMPLIANCE OFFICER ICSI M. NO. F12932 MUFG Intime India Private Limited (Formerly Link Intime India Private Limited) CIN: U67190MH1999PTC118368 Registered Address: C-101, Embassy 247, L.B.S. Marg, Vikhroli (West), Mumbai - 400083. Tel: +91 22 4918 6000 www.in.mpms.mufg.com Date : 01-07-2026 The Compliance Officer/ Company Secretary AARTI DRUGS LIMITED REGD OFFICE ADDRESS : PLOT NO. N - 198, MIDC TARAPUR, VILLAGE - PAMTERMBHI, DIST PALGHAR THANE PINCODE : 401506 Sub : Confirmation Certificate under Regulation 74(5) of Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018. Dear Sir/Madam, In reference to the above captioned regulation, we hereby confirm that the securities received from the depository participants for dematerialisation during the quarter ended 30th June 2026, were confirmed (accepted/rejected) to the depositories by us and that securities comprised in the said certificates have been listed on the stock exchanges where the earlier issued securities are listed. We hereby also confirm that the security certificates received for dematerialisation have been confirmed/rejected and the security certificates received were mutilated and cancelled after due verification by the depository participant and the name of the depositories have been substituted in the register of members as the registered owner within the prescribed timelines. We request you to kindly take note of the above in your records. Thanking you, Yours faithfully, For MUFG Intime India Private Limited (Formerly Link Intime India Private Limited) Ashok Shetty Sr. Vice President-Corporate Registry MUFG Intime India Private Limited A part of MUFG Corporate Markets, a division of MUFG Pension & Market Services